Barclays aided CIPLAQCIL start manufacture of drugs.
No Thumbnail Available
Date
2017-09-04
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
New Vision
Abstract
Malaria and HIV/AIDS are the leading causes of mortality and morbidity in Uganda at a rate 478 cases per 1,000 people and 230 registered new infections per day respectively. This is what inspired the proprietors of quality Chemicals industries Limited (CIPLAQCIL) to venture into manufacturing medicines that would positively change the situation.
Description
Newspaper article
Keywords
Citation
Mutegeki, G. (2017). Barclays aided CIPLAQCIL start manufacture of drugs. New Vision.